Inverse Relation Between the tumor Necrosis Factor Promoter Methylation and Trascript Leveles in Leukocytes From Patients with Rheumatoid Arthritis.

被引：0
|
作者：
Maxwell, James R.
Taylor, Lyndsey H.
Pachecho, Richardo A.
Lawrence, Neil
Duff, Gordon W. [2 ]
Teare, M. Dawn
Wilson, Anthony G. [1 ]
机构：
[1] Univ Sheffield, Sect Musculoskeletal Sci, Sheffield, S Yorkshire, England
[2] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
985
引用
收藏
页码：S427 / S427
页数：1
相关论文
共 50 条
  • [31] Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis
    Agarwal, Sandeep K.
    Glass, Roberta J.
    Shadick, Nancy A.
    Coblyn, Jonathan S.
    Anderson, Ronald J.
    Maher, Nancy E.
    Weinblatt, Michael E.
    Solomon, Daniel H.
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (09) : 1737 - 1744
  • [32] Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at-308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor
    Marotte, Hubert
    Arnaud, Beatrice
    Diasparra, Jennifer
    Zrioual, Saloua
    Miossec, Pierre
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1258 - 1263
  • [33] Polymorphism in the tumor necrosis factor receptor II gene is associated with soluble receptor levels in rheumatoid arthritis.
    Glossop, JR
    Dawes, PT
    Hassell, AB
    Mattey, DL
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S357 - S357
  • [34] Effects of anti-tumor necrosis factor (TNF) therapy and methotrexate on bone density in rheumatoid arthritis.
    Coulson, Kathryn
    Pepmueller, Peri
    Hinkle, Kim
    Kremer, Joel
    Reed, George
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S79 - S80
  • [35] Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis.
    McInnes I.B.
    Gracie J.A.
    [J]. Current Rheumatology Reports, 2004, 6 (5) : 336 - 342
  • [36] Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis
    Schmeling, H
    Wagner, U
    Peterson, A
    Horneff, G
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : 103 - 108
  • [37] Tumor necrosis factor-alpha and Interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients
    Ates, Omer
    Hatemi, Gulen
    Hamuryudan, Vedat
    Topal-Sarikaya, Aysegul
    [J]. CLINICAL RHEUMATOLOGY, 2008, 27 (10) : 1243 - 1248
  • [38] Tumor necrosis factor-alpha and Interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients
    Omer Ates
    Gulen Hatemi
    Vedat Hamuryudan
    Aysegul Topal-Sarikaya
    [J]. Clinical Rheumatology, 2008, 27
  • [39] Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians
    Barton, A
    John, S
    Ollier, WER
    Silman, A
    Worthington, J
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (01): : 61 - 65
  • [40] Efficacy of Total Arthroplasty Combined with Anti-Tumor Necrosis Factor Agents on Systemic Disease Activity in Patients with Rheumatoid Arthritis.
    Hayashi, Masatoshi
    Kojima, Toshihisa
    Ishiguro, Naoki
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S414 - S414
12345